Invention Application
- Patent Title: POLYCYCLIC MOLECULAR COMPOUNDS
- Patent Title (中): 多环分子化合物
-
Application No.: PCT/AU2007/001857Application Date: 2007-11-30
-
Publication No.: WO2008064432A1Publication Date: 2008-06-05
- Inventor: KASSIOU, Michael , COSTER, Mark , GUNOSEWOYO, Hendra
- Applicant: THE UNIVERSITY OF SYDNEY , KASSIOU, Michael , COSTER, Mark , GUNOSEWOYO, Hendra
- Applicant Address: Parramatta Road Sydney, NSW 2006 AU
- Assignee: THE UNIVERSITY OF SYDNEY,KASSIOU, Michael,COSTER, Mark,GUNOSEWOYO, Hendra
- Current Assignee: THE UNIVERSITY OF SYDNEY,KASSIOU, Michael,COSTER, Mark,GUNOSEWOYO, Hendra
- Current Assignee Address: Parramatta Road Sydney, NSW 2006 AU
- Agency: SHELSTON IP
- Priority: AU2006906739 20061201
- Main IPC: C07C233/65
- IPC: C07C233/65 ; C07C49/417 ; A61K51/04 ; C07C69/74 ; C07C235/40 ; A61P29/00 ; C07C233/58 ; C07C61/15 ; C07C255/47 ; C07C211/25 ; A61K31/166 ; C07C255/31 ; A61P25/28 ; A61K31/03 ; C07C61/12 ; A61P19/02 ; C07C211/19
Abstract:
This invention relates to compounds of Formula (I), wherein A is a carboaromatic or heteroaromatic ring having one or more substituents; R 6 Formula (A) is optionally substituted with one or more substituents; and n is 0, 1 or an integer greater than 1 and when n is 1 or greater the bond or bonds between the carbon atoms may be saturated or unsaturated, which bind the P2X 7 receptor with high affinity. This invention also relates to methods for the diagnosis, treatment or monitoring of disorders in which the P2X 7 receptor is implicated, in particular the diagnosis, treatment or monitoring of (the progression of) neuroinflammatory and neurodegenerative disorders in a subject.
Information query